Agile Therapeutics Inc. Daily Stock Analysis

Daily Stock Analysis, AGRX, Agile Therapeutics Inc, priceseries

Agile Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
0.28
Close
0.25
High
0.29
Low
0.25
Previous Close
0.28
Daily Price Gain
-0.03
YTD High
0.53
YTD High Date
Jan 3, 2022
YTD Low
0.25
YTD Low Date
Mar 7, 2022
YTD Price Change
-0.26
YTD Gain
-51.06%
52 Week High
2.46
52 Week High Date
Mar 10, 2021
52 Week Low
0.25
52 Week Low Date
Mar 7, 2022
52 Week Price Change
-1.86
52 Week Gain
-88.01%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 15. 2017
2.36
Apr 5. 2017
2.96
15 Trading Days
25.24%
Link
LONG
Apr 24. 2017
3.08
May 5. 2017
3.40
9 Trading Days
10.34%
Link
LONG
Jul 12. 2017
3.87
Jul 26. 2017
4.60
10 Trading Days
18.77%
Link
LONG
Sep 20. 2017
3.73
Oct 16. 2017
4.95
18 Trading Days
32.84%
Link
LONG
Nov 17. 2017
4.57
Dec 5. 2017
4.85
11 Trading Days
6.16%
Link
LONG
Mar 8. 2019
1.14
Mar 22. 2019
1.46
10 Trading Days
28.12%
Link
LONG
Jun 10. 2019
1.27
Jul 5. 2019
1.41
18 Trading Days
10.86%
Link
LONG
Sep 3. 2019
1.12
Sep 17. 2019
1.31
10 Trading Days
17.04%
Link
LONG
Nov 1. 2019
1.35
Nov 15. 2019
1.82
10 Trading Days
34.78%
Link
LONG
Dec 30. 2019
2.46
Jan 15. 2020
2.86
11 Trading Days
16.43%
Link
LONG
Jan 23. 2020
3.08
Feb 13. 2020
3.80
15 Trading Days
23.22%
Link
LONG
Apr 8. 2020
1.90
Apr 21. 2020
2.15
8 Trading Days
13.16%
Link
LONG
Apr 22. 2020
2.19
May 6. 2020
2.37
10 Trading Days
8.33%
Link
LONG
Sep 9. 2020
3.16
Sep 21. 2020
3.41
8 Trading Days
7.77%
Link
LONG
Feb 3. 2021
2.96
Feb 18. 2021
3.33
10 Trading Days
12.58%
Link
LONG
Aug 24. 2021
1.05
Sep 10. 2021
1.18
12 Trading Days
11.97%
Link
Company Information
Stock Symbol
AGRX
Exchange
NasdaqGM
Company URL
http://www.agiletherapeutics.com
Company Phone
609-683-1880
CEO
Al Altomari
Headquarters
New Jersey
Business Address
101 POOR FARM ROAD, PRINCETON, NJ 08540-1715
Sector
Equity
Industry Category
Drugs
Industry Group
Drugs - Generic
CIK
0001261249
About

Agile Therapeutics, Inc. engages in the development and commercialization of new prescription contraceptive products. Its product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company was founded on December 22, 1997 and is headquartered in Princeton, NJ.

Description

Agile Therapeutics, Inc., a forward-thinking women's healthcare company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, also known as AG200-15, a once-weekly contraceptive patch, which completed Phase III clinical trials. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading